This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 908962
Submitted by lobbyist on: January 28, 2019 12:34:21 PM
Accepted by Registrar on: January 28, 2019 02:35:25 PM
Designated Filer Information
Grover, Kelly |
Cystic Fibrosis Canada Cystic Fibrosis Canada, 2323 Y | |
Toronto, ON, M4P 2C9
|
416-485-9149 |
Canada |
Organization Information
Cystic Fibrosis Canada |
Cystic Fibrosis Canada is a national charitable not-for-profit corporation established in 1960, and is one of the world's top three charitable organizations committed to finding a cure for cystic fibrosis (CF). As an internationally recognized leader in funding innovation and clinical care, we invest more in life-saving CF research and care than any other non-governmental agency in Canada. |
2323 Yonge Street 8th Floor | |
Toronto, BC, M4P 2C9
|
416-485-9149 |
Canada |
Relevant Affiliates
Type:
Business Name | Mailing Address | Contact Information |
---|---|---|
Canadian Coalition for Genetic Fairness |
151 Frederick St, Suite 400
Kitchener, ON N2H 2M2 Canada |
Phone: 800-998-7398 |
Canadian Organization for Rare Disorders (CORD) |
151 Bloor Street West, Suite 6
Toronto , ON M5S 1S4 Canada |
Phone: 416-969-7464 |
Episodic Disabilities Network |
1240 Bay Street, Suite 600
Toronto, ON M5R 2A7 Canada |
Phone: 416-513-0440 |
Health Charities Coalition of Canada |
Annex D, 41 Empress Ave
Ottawa, ON K1R 7E9 Canada |
Phone: 613-440-4411 |
Government or Government Agency Funding
Name of Funding provider | Amount in CAD$ |
---|---|
BC Ministry of Health | $230,000.00 |
Provincial Health Services Authority | $80,000.00 |
Other Controlling or Directing Interests
Active Registration Period
January 28, 2019 | |
July 28, 2019 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Patient group submission to PharmaCare Review for provincial coverage for CF drug Orkambi. Developing and implementing an integrated care model for CF, funding and strategy to support mental health projects.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Minister | Dix, Adrian | Minister of Health | January 28, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Patient group submission to PharmaCare Review for provincial coverage for CF drug Orkambi. Developing and implementing an integrated care model for CF, funding and strategy to support mental health projects.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Minister | Dix, Adrian | Minister of Health | January 28, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Patient group submission to PharmaCare Review for provincial coverage for CF drug Orkambi. Developing and implementing an integrated care model for CF, funding and strategy to support mental health projects.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Minister | Dix, Adrian | Minister of Health | January 28, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Patient group submission to PharmaCare Review for provincial coverage for CF drug Orkambi. Developing and implementing an integrated care model for CF, funding and strategy to support mental health projects.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Minister | Dix, Adrian | Minister of Health | January 28, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Patient group submission to PharmaCare Review for provincial coverage for CF drug Orkambi. Developing and implementing an integrated care model for CF, funding and strategy to support mental health projects.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Minister | Dix, Adrian | Minister of Health | January 28, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Patient group submission to PharmaCare Review for provincial coverage for CF drug Orkambi. Developing and implementing an integrated care model for CF, funding and strategy to support mental health projects.
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Minister | Dix, Adrian | Minister of Health | January 28, 2019 |